Sign In
Buy DXCM
$72.77
-0.680 (-0.93%)
At Close: Jun 03, 2026
The 7 Best Nasdaq Stocks To Buy Now: October 2023
09:15am, Thursday, 19'th Oct 2023
Nasdaq stocks generally equate to higher-growth, technology-dominated firms in the eyes of most investors. The index is generally more rate-sensitive than leading indexes like the Dow and the S&P 500.
4 Medical Product Stocks Set to Outpace Q3 Earnings Estimates
08:16am, Thursday, 19'th Oct 2023
Medical Product companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how EW, PODD, DXCM and IQV are poised ahead of their earnings release.
Can DexCom (DXCM) Keep the Earnings Surprise Streak Alive?
01:32pm, Wednesday, 18'th Oct 2023
DexCom (DXCM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
2 Healthcare Stocks Near Their 52-Week Lows That Could Double in Value
09:53am, Wednesday, 18'th Oct 2023
DexCom is a big name in diabetes care, and investors may be overly bearish on the stock. InMode recently downgraded its guidance as rising interest rates impact its sales activity.
Is the Ozempic-Driven DexCom Selloff Overdone?
06:30am, Wednesday, 18'th Oct 2023
Plenty of businesses, such as PepsiCo Inc. NYSE: PEP and Walmart Inc. NYSE: WMT, have been under the microscope on fears of potential earnings decreases due to growing use of products like Novo Nordis
3 Stock-Split Stocks With 110% to 696% Upside, According to Select Wall Street Analysts and Pundits
05:06am, Wednesday, 18'th Oct 2023
When stock-market volatility picks up, investors tend to gravitate to outperforming companies that have enacted stock splits. Nine high-profile companies have conducted forward-stock splits since the
Why the Market Dipped But DexCom (DXCM) Gained Today
07:33pm, Tuesday, 17'th Oct 2023
The latest trading day saw DexCom (DXCM) settling at $80.49, representing a +1.95% change from its previous close.
MedTech Earnings in the Age of Ozempic May Not Be That Bad
02:01pm, Tuesday, 17'th Oct 2023
September-quarter earnings among medical-device makers may prove better than expected in the age of weight-loss drugs.
Why DexCom Stock Rallied on Monday
03:15pm, Monday, 16'th Oct 2023
The dramatic weight loss resulting from a new breed of diabetes medication has weighed on DexCom stock. As with all things, however, the devil is in the details.
What other industries could weight loss drugs disrupt?
07:10pm, Wednesday, 11'th Oct 2023
Jared Holz, Mizuho health care sector strategist, joins the ‘Fast Money' traders to discuss Novo Nordisj's kidney trial outcomes and the impact of weight loss drugs on the health care sector.
A Bull Market Is Coming: 2 Magnificent Stock-Split Growth Stocks That Could Soar 40% and 51%, According to Wall Street
07:00am, Sunday, 08'th Oct 2023
While stocks are taking a breather from their recent run, a bull market is on the horizon. Investor interest in stock-split stocks continues, as these stocks have historically generated strong gains o
Diabetes-related stocks take hit over weight loss drug craze
01:00pm, Saturday, 07'th Oct 2023
This segment originally aired on October 5, 2023 Weight loss drugs, like Novo Nordisk's (NVO) Ozempic, have become popular across healthcare providers in regard to diabetes treatment. Although use is
Glucose Game-Changers: 3 Diabetes Stocks to Grab on the Downturn
05:53am, Wednesday, 04'th Oct 2023
In recent months, diabetes stocks have retreated sharply, partly due to the increased popularity of the weight-loss drug Semaglutide. Some have contended that Semaglutide will greatly reduce the numbe
Weight-Loss-Drug Stock Sting May Be Easing for Device Makers
01:59pm, Monday, 02'nd Oct 2023
Wall Street says insulin pump maker Insulet and Tandem Diabetes, as well as glucose-monitor maker DexCom, look ready to rise after pressure from Novo Nordisk's Wegovy and Eli Lilly.
Dexcom Schedules Third Quarter 2023 Earnings Release and Conference Call for October 26, 2023 at 4:30 p.m. Eastern Time.
08:30am, Friday, 29'th Sep 2023
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its third quarter 2023 financial results after market close on Thursday, October 26, 2023. Management wi
